The most extensively investigated epigenetic mark in GBM is the methylation of the MGMT gene promoter, which is an independent prognostic factor for favorable tumor biology and a beneficial predictor of response to TMZ and radiotherapy [22]. Here, MGMT is linked to neoplasm.